Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CULP | US
-0.14
-2.30%
Consumer Cyclical
Textile Manufacturing
31/07/2024
04/10/2024
5.95
5.85
6.10
5.51
Culp Inc. manufactures sources markets and sells mattress fabrics sewn covers and cut and sewn kits for use in mattresses foundations and other bedding products in the United States North America the Far East Asia and internationally. It operates in two segments Mattress Fabrics and Upholstery Fabrics. The Mattress Fabrics segment offers woven jacquard knitted and converted fabrics for use in the production of bedding products including mattresses box springs foundations and top of bed components. The Upholstery Fabrics segment provides jacquard woven fabrics velvets micro denier suedes woven dobbies knitted fabrics piece-dyed woven products and polyurethane fabrics for use in the production of residential and commercial upholstered furniture such as sofas recliners chairs loveseats sectionals and sofa-beds as well as office seating and window treatment products; and installation services for customers in the hospitality and commercial industries. Culp Inc. was founded in 1972 and is headquartered in High Point North Carolina.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
64.2%1 month
54.4%3 months
43.4%6 months
34.7%-
10.57
1.08
0.11
0.06
-57.36
0.31
0.59
-5.29M
74.32M
74.32M
-
-7.46
-63.40
-0.20
-22.85
1.41
0.31
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.34
Range1M
2.18
Range3M
2.36
Rel. volume
0.68
Price X volume
161.09K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.44 | 54.51M | 0.70% | n/a | 25.73% |
Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.1014 | 42.58M | 4.54% | n/a | 0.00% |
DURECT Corporation | DRRX | Drug Manufacturers-Specialty & Generic | 1.24 | 38.49M | -7.46% | n/a | 318.92% |
India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.3705 | 28.02M | -3.89% | n/a | 4.33% |
Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 4.66 | 25.85M | 9.65% | n/a | 0.00% |
Flora Growth Corp. Common Stock | FLGC | Drug Manufacturers-Specialty & Generic | 1.56 | 20.85M | -8.77% | n/a | 76.81% |
MEI Pharma Inc | MEIP | Drug Manufacturers-Specialty & Generic | 2.81 | 18.72M | 2.18% | 1.09 | 0.00% |
Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 1.25 | 17.62M | 0.81% | n/a | 81.86% |
Marpai Inc. Class A Common Stock | MRAI | Healthcare Plans | 0.6 | 8.24M | 27.52% | n/a | -15.38% |
BGXX | BGXX | Drug Manufacturers-Specialty & Generic | 0.0365 | 7.16M | 1.11% | n/a | 5.20% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -57.36 | - | - |
Ent. to Revenue | 0.31 | - | - |
PE Ratio | - | - | - |
Price to Book | 1.08 | - | - |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 43.43 | - | - |
Debt to Equity | 0.11 | - | - |
Debt to Assets | 0.06 | - | - |
Market Cap | 74.32M | - | - |